UBS Group AG - PROCESSA PHARMACEUTICALS INC ownership

PROCESSA PHARMACEUTICALS INC's ticker is PCSA and the CUSIP is 74275C205. A total of 19 filers reported holding PROCESSA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PROCESSA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$177
-98.4%
707
-96.9%
0.00%
Q1 2023$11,230
+274.3%
22,459
+1914.3%
0.00%
Q1 2022$3,000
+200.0%
1,115
+411.5%
0.00%
Q4 2021$1,000
-80.0%
218
-60.1%
0.00%
Q3 2021$5,000546
+1200.0%
0.00%
Q2 2021$0420.00%
Other shareholders
PROCESSA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Coastal Bridge Advisors, LLC 52,500$13,1360.00%
Mirador Capital Partners LP 19,516$4,8830.00%
WELLS FARGO & COMPANY/MN 3,238$8100.00%
NORTHERN TRUST CORP 15,401$3,8530.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 152,670$38,9300.00%
STATE STREET CORP 42,786$10,9100.00%
MILLENNIUM MANAGEMENT LLC 25,930$6,6120.00%
BlackRock Inc. 293$730.00%
Citadel Advisors 166,224$42,3870.00%
View complete list of PROCESSA PHARMACEUTICALS INC shareholders